Drug Profile
Doxepin low dose - Somaxon Pharmaceuticals
Alternative Names: Doxepin low dose; Silenor; SO-101Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Somaxon Pharmaceuticals
- Developer Endo International; Somaxon Pharmaceuticals
- Class Antipruritics; Dibenzoxepins; Oxepins; Sleep disorder therapies; Small molecules; Tricyclic antidepressants
- Mechanism of Action Histamine H1 receptor antagonists; Neurotransmitter uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Insomnia